SEC Form 10-Q Summary
Filing entity: Agrify Corporation (NASDAQ: AGFY). The request identifies RYTHM, Inc., but the filing text is for Agrify Corporation. Reporting period ended September 30, 2021; results are unaudited and presented in thousands except per-share and share data.
Business Context and Reporting Period
Agrify develops precision hardware and software solutions for indoor agriculture and provides equipment, extraction, post-processing, testing, facility build-out, consulting, and construction services for the cannabis and hemp industries. Revenue is generated primarily from cultivation solutions, facility build-outs, and related services.
The company completed its IPO and a subsequent public offering during 2021, raising approximately $57 million and $80 million, respectively, net of offering costs. Outstanding common shares were 21,261,383 at September 30, 2021 and 21,270,977 as of November 9, 2021.
Financial Results and Key Metrics
| Metric | Three Months Ended September 30 | Nine Months Ended September 30 |
|---|---|---|
| Revenue | $15.751 million, versus $2.813 million | $34.584 million, versus $7.734 million |
| Gross profit (loss) | $(0.380) million, versus $(0.199) million | $(0.393) million, versus $0.860 million |
| Gross margin | (2.4%), versus (7.1%) | (1.1%), versus 11.1% |
| Operating loss | $(9.802) million, versus $(2.585) million | $(21.726) million, versus $(8.472) million |
| Net loss attributable to Agrify | $(9.758) million, versus $(2.705) million | $(19.204) million, versus $(8.562) million |
| Loss per share | $(0.47), versus $(0.67) | $(1.07), versus $(2.13) |
Third-quarter revenue growth was driven primarily by facility build-outs of $12.995 million and sales of 114 AVFUs, compared with no AVFU sales in the prior-year quarter. Nine-month facility build-out revenue was $30.466 million, while cultivation-solution revenue declined to $3.969 million from $4.594 million. Revenue concentration remained high: five customers represented 94.4% of third-quarter revenue and three customers represented 78.4% of nine-month revenue.
Operating expenses increased to $9.422 million in the third quarter and $21.333 million for the nine-month period. Nine-month selling, general and administrative expense was $18.850 million, including stock-based compensation, higher payroll, insurance, legal, marketing, and a $2.4 million one-time financing termination payment.
Cash Flow, Liquidity, Debt, and Balance Sheet
- Cash and cash equivalents were $44.746 million at September 30, 2021, compared with $8.111 million at December 31, 2020.
- Current and non-current marketable securities totaled $68.514 million, and the company held a $13.092 million loan receivable.
- Total assets were $159.298 million, compared with $21.839 million at year-end 2020. Stockholders’ equity was $134.297 million, compared with a deficit of $6.679 million.
- Net cash used in operating activities was $17.557 million, compared with $10.723 million in the prior-year period.
- Net cash used in investing activities was $84.683 million, including $68.461 million of held-to-maturity securities purchases, $12.686 million of loan funding, and $3.536 million of capital expenditures.
- Net cash provided by financing activities was $138.875 million, principally from the IPO and secondary offering.
- Notes payable and derivative liabilities were eliminated through conversion or extinguishment. Remaining long-term debt was $0.833 million, primarily related to the PPP loan and other financing obligations.
- Management stated that available funds were expected to support planned operations for at least the next 12 months, but noted potential future dependence on operating cash generation and additional financing.
Material Changes, Outlook, and Risks
- Gross profitability deteriorated for the nine-month period despite substantial revenue growth, reflecting higher outside production costs, product-related costs, AVFU discounts, and a less favorable revenue mix.
- The Agrify Total Turnkey Solution was funded through customer loans. The company had committed $9.933 million to five TTK customers and $3.159 million to one non-TTK customer at September 30, 2021. Loans generally carry approximately 20% annual interest and mature two to three years after the first commercial harvest.
- The company increased its Mack Molding purchase order for AVFUs to approximately $11.5 million for production during 2021 and 2022, creating execution, supplier, and demand risks.
- On October 1, 2021, after the reporting date, Agrify acquired Cascade Sciences and Precision Extraction Solutions. Consideration included $30 million in cash, approximately $20 million in Agrify stock subject to adjustment, and potential earnout consideration, with aggregate purchase price capped at $65 million.
- COVID-19-related supply-chain disruptions, product shortages, pricing volatility, and construction execution could continue to affect revenue, margins, and delivery schedules.
- The company is subject to litigation brought by former TriGrow employees alleging compensation, employment, fiduciary, and securities-related claims. The company disputes the claims and is defending them; the filing does not provide a clear potential loss amount.
- Disclosure controls and procedures were not effective as of September 30, 2021. Management identified material weaknesses and is implementing remediation measures, including additional qualified personnel, documented controls, and control monitoring.
- No formal quantitative revenue or earnings guidance is provided in the filing. Management expects continued investment in AVFUs and Agrify Insights software and believes research and development expense as a percentage of revenue may decline as revenue grows.
Important Facts to Verify
- Confirm the correct issuer, because the supplied metadata names RYTHM, Inc. while the filing is Agrify Corporation.
- Assess whether recurring AVFU and software revenue can scale beyond facility build-out revenue without further margin deterioration.
- Evaluate customer concentration, collectability of the $13.092 million loan receivable, and the credit risk of the TTK customer portfolio.
- Review funding needs after the Precision-Cascade acquisition, continuing operating losses, negative operating cash flow, and planned investments.
- Quantify potential dilution from 3.511 million outstanding options, 271,844 warrants, acquisition consideration, and future equity offerings.
- Review the ineffective disclosure controls and material weakness remediation progress.
- Verify the financial and operational impact of the post-quarter Precision-Cascade acquisition, including purchase accounting, earnouts, integration costs, and financing.
- Monitor litigation, supply commitments, COVID-19 effects, supplier dependence, and the company’s ability to achieve sustainable positive gross margins.